SARS-CoV-2 infects cells via its spike protein binding to its surface receptor on target cells
and results in acute symptoms involving especially the lungs known as COVID-19. However …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since
2020. Links between the newly discovered viral infection and the pathogenesis of …

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin
converting enzyme 2 (ACE2) on target cells and results in acute symptoms involving …

COVID‐19 is associated with encephalitis in critically ill patients and endothelial dysfunction
seems to contribute to this life‐threatening complication. Our objective was to determine the …

Background: Observational studies have suggested an association between coronavirus
disease 2019 (COVID‐19) and myasthenia gravis (MG). Here, we aimed to estimate the …

Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase
and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell …

Accumulating data suggest that chronic neuroinflammation-mediated neurodegeneration is
a significant contributing factor for progressive neuronal and glial cell death in age-related …

Rapid infectivity of SARS-CoV2 with recent viral variants is posing a challenge in the
development of robust therapeutic strategies. On the other hand, microbiota is debated for its …